133 related articles for article (PubMed ID: 21098846)
41. Two-stage first-trimester screening for trisomy 21 by ultrasound assessment and biochemical testing.
Kagan KO; Staboulidou I; Cruz J; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2010 Nov; 36(5):542-7. PubMed ID: 20503223
[TBL] [Abstract][Full Text] [Related]
42. [Investigation of ultrasound markers in screening fetal trisomy 21].
Shi XM; Fang Q; Chen BJ; Xie HN; Xie YJ; Chen JH; Wu JZ
Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):81-5. PubMed ID: 23544486
[TBL] [Abstract][Full Text] [Related]
43. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
Kagan KO; Cicero S; Staboulidou I; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Mar; 33(3):259-64. PubMed ID: 19248005
[TBL] [Abstract][Full Text] [Related]
44. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
[TBL] [Abstract][Full Text] [Related]
45. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
[TBL] [Abstract][Full Text] [Related]
46. Assessment of the ductus venosus, tricuspid blood flow and the nasal bone in second-trimester screening for trisomy 21.
Stressig R; Kozlowski P; Froehlich S; Siegmann HJ; Hammer R; Blumenstock G; Kagan KO
Ultrasound Obstet Gynecol; 2011 Apr; 37(4):444-9. PubMed ID: 20645398
[TBL] [Abstract][Full Text] [Related]
47. Interobserver variability of the measurement of fetal nasal bone length between 11+0 and 13+6 gestation weeks among experienced and inexperienced sonographers.
Staboulidou I; Wüstemann M; Vaske B; Scharf A; Hillemanns P; Schmidt P
Ultraschall Med; 2009 Feb; 30(1):42-6. PubMed ID: 18773384
[TBL] [Abstract][Full Text] [Related]
48. Absent or shortened nasal bone length and the detection of Down Syndrome in second-trimester fetuses.
Gianferrari EA; Benn PA; Dries L; Brault K; Egan JF; Zelop CM
Obstet Gynecol; 2007 Feb; 109(2 Pt 1):371-5. PubMed ID: 17267838
[TBL] [Abstract][Full Text] [Related]
49. Nuchal fold thickness, nasal bone absence or hypoplasia, ductus venosus reversed flow and tricuspid valve regurgitation in screening for trisomies 21, 18 and 13 in the early second trimester.
Geipel A; Willruth A; Vieten J; Gembruch U; Berg C
Ultrasound Obstet Gynecol; 2010 May; 35(5):535-9. PubMed ID: 20183867
[TBL] [Abstract][Full Text] [Related]
50. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome.
Spencer K; Crossley JA; Aitken DA; Nix AB; Dunstan FD; Williams K
Ann Clin Biochem; 2003 May; 40(Pt 3):219-31. PubMed ID: 12803832
[TBL] [Abstract][Full Text] [Related]
51. Screening performance of different methods defining fetal nasal bone hypoplasia as a single and combined marker for the detection of trisomy 21 in the second trimester.
Papasozomenou P; Athanasiadis AP; Zafrakas M; Panteris E; Mikos T; Daniilidis A; Loufopoulos A; Assimakopoulos E; Tarlatzis BC
J Matern Fetal Neonatal Med; 2016 Oct; 29(20):3368-73. PubMed ID: 26635074
[TBL] [Abstract][Full Text] [Related]
52. Fetal nasal bone and trisomy 21 in the second trimester.
Viora E; Errante G; Sciarrone A; Bastonero S; Masturzo B; Martiny G; Campogrande M
Prenat Diagn; 2005 Jun; 25(6):511-5. PubMed ID: 15968623
[TBL] [Abstract][Full Text] [Related]
53. Comparison of serum markers in first-trimester down syndrome screening.
Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
[TBL] [Abstract][Full Text] [Related]
54. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A
Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324
[TBL] [Abstract][Full Text] [Related]
55. Likelihood ratios for fetal trisomy 21 based on nasal bone length in the second trimester: how best to define hypoplasia?
Cusick W; Shevell T; Duchan LS; Lupinacci CA; Terranova J; Crombleholme WR
Ultrasound Obstet Gynecol; 2007 Sep; 30(3):271-4. PubMed ID: 17721915
[TBL] [Abstract][Full Text] [Related]
56. Fetal nasal bone assessment in first trimester down syndrome screening.
Has R; Kalelioglu I; Yuksel A; Ibrahimoglu L; Ermis H; Yildirim A
Fetal Diagn Ther; 2008; 24(1):61-6. PubMed ID: 18504384
[TBL] [Abstract][Full Text] [Related]
57. Combined sonographic and biochemical markers for Down syndrome screening.
Pinette MG; Egan JF; Wax JR; Blackstone J; Cartin A; Benn PA
J Ultrasound Med; 2003 Nov; 22(11):1185-90. PubMed ID: 14620889
[TBL] [Abstract][Full Text] [Related]
58. Correlation of ultrasound findings and biochemical markers in the second trimester of pregnancy in fetuses with trisomy 21.
Souter VL; Nyberg DA; El-Bastawissi A; Zebelman A; Luthhardt F; Luthy DA
Prenat Diagn; 2002 Mar; 22(3):175-82. PubMed ID: 11920888
[TBL] [Abstract][Full Text] [Related]
59. Nasal bone in first-trimester screening for trisomy 21.
Cicero S; Avgidou K; Rembouskos G; Kagan KO; Nicolaides KH
Am J Obstet Gynecol; 2006 Jul; 195(1):109-14. PubMed ID: 16813749
[TBL] [Abstract][Full Text] [Related]
60. Nasal bone evaluation in fetuses with Down syndrome during the second and third trimesters of pregnancy.
Lee W; DeVore GR; Comstock CH; Kalache KD; McNie B; Chaiworapongsa T; Conoscenti G; Treadwell MC; Johnson A; Huang R; Romero R
J Ultrasound Med; 2003 Jan; 22(1):55-60. PubMed ID: 12523611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
